Acadia Healthcare Company Inc vs Ares Capital Corporation — how do they compare? Acadia Healthcare Company Inc trades at $30.78 (market cap $2.90B), while Ares Capital Corporation trades at $19.93 (market cap $14.34B). The key difference: Ares Capital Corporation is far larger — about 4.9× Acadia Healthcare Company Inc's market cap, and Ares Capital Corporation pays a 9.61% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | ARCC | |
|---|---|---|
Market Cap | $2.90B | $14.34B |
Sector | Health | Financials |
52-Week High | $35.61 | $22.68 |
52-Week Low | $11.68 | $17.45 |
Enterprise Value | $5.29B | — |
Dividend Yield | — | 9.61% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ARCC trades at $19.98, down 0.15% on the day, with a P/E of 14.9 and P/B of 1.03. Recent quarterly earnings have consistently missed expectations, with Q2 2026 EPS of $0.47 falling short of the $0.4731 estimate. Technical indicators show a bullish moving average signal but bearish oscillators, with RSI at 78.37 suggesting overbought conditions. The company maintains a strong dividend yield of approximately 9.6% with consistent $0.48 quarterly payments.
While ARCC offers attractive income with its high dividend yield and strong analyst support (24 buy ratings), investors face risks from declining revenue trends and compressed earnings. The stock trades near consensus price targets, limiting near-term upside potential. Credit quality concerns in the private lending sector and potential interest rate sensitivity present additional headwinds for this business development company.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →